More about

University Of California Los Angeles

News
March 30, 2020
1 min read
Save

FDA approves Imfinzi for extensive-stage small cell lung cancer

FDA approves Imfinzi for extensive-stage small cell lung cancer

The FDA approved durvalumab in combination with standard chemotherapy as first-line treatment of adults with extensive-stage small cell lung cancer.

News
March 20, 2020
2 min read
Save

Shorter neoadjuvant radiotherapy regimen effective, safe in soft tissue sarcoma

Shorter neoadjuvant radiotherapy regimen effective, safe in soft tissue sarcoma

A 5-day regimen of neoadjuvant radiotherapy appeared as effective and safe as the conventional 5-week regimen for patients with soft tissue sarcoma, according to results of a prospective phase 2 study published in Clinical Cancer Research.

News
February 18, 2020
3 min read
Save

Are people with Cushing’s disease refractory to surgery and radiotherapy better served with long-term pharmacotherapy or bilateral adrenalectomy?

Are people with Cushing’s disease refractory to surgery and radiotherapy better served with long-term pharmacotherapy or bilateral adrenalectomy?

The Endocrine Society recommends medical management with a moderate level of evidence; in particular, steroidogenesis inhibitors as a second-line treatment after surgery for people with Cushing’s disease, either with or without radiotherapy, and as primary treatment for ectopic adrenocorticotropic hormone (ACTH) secretion. The guideline also recommends pituitary-directed medical treatments for patients who are not surgical candidates or who have persistent disease after surgery. The choice of medical therapy should be guided by efficacy, individual patient factors and cost.

News
January 10, 2020
3 min read
Save

Partial breast reirradiation ‘viable alternative to mastectomy’ for certain women with breast cancer recurrence

Partial breast reirradiation without mastectomy appeared as effective as mastectomy for treatment of breast cancer recurrence in the ipsilateral breast after lumpectomy and whole breast irradiation, according to results of the phase 2 NRG Oncology/RTOG1014 trial published in JAMA Oncology.

News
December 13, 2019
4 min read
Save

Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence

Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence

SAN ANTONIO — Two common hormone therapy regimens had opposite long-term effects on breast cancer incidence among postmenopausal women, according to results from two large randomized controlled Women’s Health Initiative trials presented at San Antonio Breast Cancer Symposium.

News
December 01, 2019
1 min read
Save

NCI gives $8.7 million grant to UCLA prostate cancer program

The NCI awarded an $8.7 million grant to the prostate cancer program at UCLA Jonsson Comprehensive Cancer Center and UCLA Health.

News
November 25, 2019
2 min read
Save

UCLA Opens Clinical Trial of Bispecific CAR T-cell Therapy for Advanced Lymphoma, Leukemia

The UCLA Jonsson Cancer Center has begun enrolling patients in its latest chimeric antigen receptor T-cell immunotherapy trial for patients with relapsed or refractory non-Hodgkin’s B-cell lymphoma or chronic lymphocytic leukemia.

News
November 20, 2019
2 min read
Save

Prevymis may be alternative to Valcyte for CMV-associated uveitis

Prevymis may be alternative to Valcyte for CMV-associated uveitis

SAN FRANCISCO — Prevymis safely resolved inflammation among patients with cytomegalovirus-associated uveitis, according to a presentation at the American Academy of Ophthalmology annual meeting.

News
October 30, 2019
5 min read
Save

Hematologists, oncologists elected to National Academy of Medicine

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

News
October 21, 2019
1 min read
Save

Cancer Research Institute honors UCLA scientist for basic, tumor immunology discoveries

Cancer Research Institute honors UCLA scientist for basic, tumor immunology discoveries

The Cancer Research Institute presented the William B. Coley Award to Antoni Ribas, MD, PhD.

View more